Haemonetics (HAE) Depreciation and Depletion (2018 - 2026)

Haemonetics' Depreciation and Depletion history runs 6 years deep, the most recent figure standing at $15.3 million for Q1 2026.

• On a quarterly basis, Depreciation and Depletion rose 0.66% year-over-year to $15.3 million in Q1 2026; TTM through Mar 2026 was $61.1 million, a 1.83% increase from a year earlier, with the FY2026 full-year figure at $61.2 million, up 2.0% from the prior year.
• Depreciation and Depletion rose to $15.3 million in Q1 2026 per HAE's latest filing, from $14.9 million in the prior quarter.
• Across five years, Depreciation and Depletion topped out at $15.5 million in Q3 2025 and bottomed at $11.7 million in Q3 2022.
• The 5-year median for Depreciation and Depletion is $14.6 million (2024), against an average of $14.3 million.
• Across the five-year window, Depreciation and Depletion increased 13.68% in 2023 and slipped 1.97% in 2025, its largest moves.
• Year by year, Depreciation and Depletion stood at $13.1 million in 2022, then climbed by 8.4% to $14.2 million in 2023, then grew by 7.04% to $15.2 million in 2024, then slipped by 1.97% to $14.9 million in 2025, then grew by 2.68% to $15.3 million in 2026.
• Per Business Quant, the three latest HAE Depreciation and Depletion figures stand at $15.3 million (Q1 2026), $14.9 million (Q4 2025), and $15.5 million (Q3 2025).